Searched for
METROPOLIS HEALTHCARE TARGET PRICE
HSBC initiates coverage on this recently listed healthcare stock that can rally up to 26%. Do you own?HSBC has initiated coverage on recently listed Manipal Health with a Buy rating and Rs 1,000 target price, implying 26% upside. The brokera...- JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upsideJM Financial has retained its Buy rating on Metropolis Healthcare with a target price of Rs 734, implying 27.2% upside. The brokerage calls...
- Yatharth Hospital shares jump 5% as Aster, Advent likely eye controlling stakeYatharth Hospital shares jumped over 5% after reports that Aster DM Quality Care, backed by Advent International and Blackstone, is negotia...
- Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
- Raising a child in India could cost nearly Rs 7 crore, financial advisor’s estimate sparks debateFinance advisor and content creator Udayan Adhye has sparked an online discussion after estimating that raising a child in an Indian metro ...
- ET Startup Awards 2026 | Top Innovator: Deeptech startup Theranautilus’ micro robots score big winDeeptech startup Theranautilus has won the Top Innovator award at the ET Startup Awards 2026 for its work on microscopic robots that can na...
- Ventura initiates coverage on Meesho and LG India, sees up to 35% upsideVentura Securities has initiated coverage on Meesho and LG Electronics India with Buy ratings, seeing up to 35% upside. The brokerage expec...
- Hindustan Zinc vs Hindalco: Why Jefferies raised target prices for both, but prefers one over the otherJefferies has raised its target prices for Hindustan Zinc and Hindalco Industries, but prefers the former, retaining a Buy rating versus Ho...
- August Energy, Energeia partner to create $100 million energy-efficiency platform in IndiaAugust Energy and Energeia launch a $100 million platform for Indian businesses. This initiative focuses on decarbonisation without upfront...
- Canada is not just challenging the US on trade – it wants its immigrants tooCanada is fighting Donald Trump on two fronts: retaliating against US tariffs while courting skilled workers affected by his immigration cr...
- Entero Healthcare shares gain 15% in 2 days after Prashant Jain’s 3P Investment picks stake in block dealEntero Healthcare Solutions shares rose sharply after Prashant Jain-owned 3P Investment Managers acquired a 2.5% stake in the company throu...
- BSE shares: Prabhudas Lilladher cuts target price to Rs 4,025 as CAS hits derivatives volumesPrabhudas Lilladher retained its ‘Buy’ rating on BSE but lowered the target price to Rs 4,025 from Rs 4,850, citing a slowdown in derivativ...
- Madhur Knit Crafts, ABH Healthcare SME IPOs Day 1: Early subscription, GMP, and key detailsMadhur Knit and ABH Healthcare SME IPOs opened on August 24, 2026, attracting early investor interest. Madhur Knit showed a 16% GMP, while ...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Hexaware Technologies shares rally 5%; Motilal Oswal reiterates buy with target price of Rs 720Hexaware Technologies shares rose on Monday after Motilal Oswal reiterated its Buy rating with a Rs 720 target, implying 35% upside. The br...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Given current market conditions, better stick with stocks that offer some comfort. It could be valuation, or growth purely dependent on dom...
- Buy, Sell or Hold: Nomura maintains neutral stance on Maruti Suzuki; Goldman Sachs recommends buy on Godrej ConsumerTop global brokerages have issued fresh calls across sectors. Nomura maintained Neutral on Maruti Suzuki expecting further price hikes, whi...
- Strong Q1 results spark stock-picking rush: 50 top ideas for investors to buyThe impressive earnings reported in the first quarter have led brokerages to unveil fresh stock-picking avenues. Investors are encouraged t...
- Buy, Sell or Hold: Elara Capital raises target price on BEML; Citi remains bullish on Titan CompanyBrokerages remain bullish on BEML, Titan and Fortis Healthcare, citing strong earnings, improving margins and growth prospects. Elara sees ...
Load More
